Fresenius Medical Care Ag (FMS)

$19.76

+0.22

(+1.13%)

Market is closed - opens 7 PM, 04 Nov 2024

Performance

  • $19.70
    $19.92
    $19.76
    downward going graph

    0.3%

    Downside

    Day's Volatility :1.1%

    Upside

    0.8%

    downward going graph
  • $16.66
    $22.76
    $19.76
    downward going graph

    15.69%

    Downside

    52 Weeks Volatility :26.8%

    Upside

    13.18%

    downward going graph

Returns

PeriodFresenius Medical Care AgSector (Health Care)Index (Russel 2000)
3 Months
3.73%
-2.1%
0.0%
6 Months
-8.77%
5.2%
0.0%
1 Year
14.55%
16.5%
0.0%
3 Years
-42.05%
9.8%
-25.1%

Highlights

Market Capitalization
11.5B
Book Value
$47.48
Dividend Share
1.19
Dividend Yield
3.29%
Earnings Per Share (EPS)
0.98
PE Ratio
19.94
PEG Ratio
0.4
Wall Street Target Price
20.08
Profit Margin
2.73%
Operating Margin TTM
7.84%
Return On Assets TTM
2.9%
Return On Equity TTM
5.06%
Revenue TTM
19.4B
Revenue Per Share TTM
33.09
Quarterly Revenue Growth YOY
-1.2%
Gross Profit TTM
5.3B
EBITDA
2.4B
Diluted Eps TTM
0.98
Quarterly Earnings Growth YOY
0.33
EPS Estimate Current Year
2.51
EPS Estimate Next Year
2.81
EPS Estimate Current Quarter
0.37
EPS Estimate Next Quarter
0.39

Analyst Recommendation

Hold
    14%Buy
    53%Hold
    32%Sell
Based on 28 Wall street analysts offering stock ratings for Fresenius Medical Care Ag(by analysts ranked 0 to 5 stars)
Based on 28 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
4
4
5
Hold
15
15
15
Sell
9
9
9

Analyst Forecast

What analysts predicted

Upside of 1.62%

Current $19.76
Target $20.08

Company Financials

FY18Y/Y Change
Revenue
18.8B
↓ 6.96%
Net Income
2.3B
↑ 54.84%
Net Profit Margin
11.98%
↑ 4.78%
FY19Y/Y Change
Revenue
19.4B
↑ 5.62%
Net Income
1.3B
↓ 39.46%
Net Profit Margin
6.87%
↓ 5.11%
FY20Y/Y Change
Revenue
21.7B
↑ 2.19%
Net Income
1.4B
↓ 2.97%
Net Profit Margin
6.52%
↓ 0.35%
FY21Y/Y Change
Revenue
19.9B
↓ 1.34%
Net Income
1.1B
↓ 16.75%
Net Profit Margin
5.5%
↓ 1.02%
FY22Y/Y Change
Revenue
20.5B
↑ 10.1%
Net Income
712.6M
↓ 30.53%
Net Profit Margin
3.47%
↓ 2.03%
FY23Y/Y Change
Revenue
21.2B
↑ 0.29%
Net Income
544.4M
↓ 25.9%
Net Profit Margin
2.57%
↓ 0.9%
Q1 FY23Q/Q Change
Revenue
5.0B
↓ 5.86%
Net Income
143.3M
↓ 31.0%
Net Profit Margin
2.85%
↓ 1.03%
Q2 FY23Q/Q Change
Revenue
5.2B
↑ 2.57%
Net Income
152.2M
↑ 4.86%
Net Profit Margin
2.91%
↑ 0.06%
Q3 FY23Q/Q Change
Revenue
5.3B
↑ 2.3%
Net Income
90.0M
↓ 39.9%
Net Profit Margin
1.71%
↓ 1.2%
Q4 FY23Q/Q Change
Revenue
5.4B
↑ 1.05%
Net Income
205.0M
↑ 122.79%
Net Profit Margin
3.77%
↑ 2.06%
Q1 FY24Q/Q Change
Revenue
5.1B
↓ 5.27%
Net Income
77.1M
↓ 62.24%
Net Profit Margin
1.5%
↓ 2.27%
Q2 FY24Q/Q Change
Revenue
4.8B
↑ 0.88%
Net Income
187.0M
↑ 163.53%
Net Profit Margin
3.92%
↑ 2.42%
FY18Y/Y Change
Total Assets
29.9B
↑ 9.23%
Total Liabilities
15.2B
↑ 1.08%
FY19Y/Y Change
Total Assets
36.6B
↑ 25.5%
Total Liabilities
21.9B
↑ 47.74%
FY20Y/Y Change
Total Assets
38.5B
↓ 3.78%
Total Liabilities
23.5B
↓ 1.78%
FY21Y/Y Change
Total Assets
38.9B
↑ 8.45%
Total Liabilities
23.0B
↑ 5.32%
FY22Y/Y Change
Total Assets
37.8B
↑ 4.04%
Total Liabilities
21.5B
↓ 0.41%
FY23Y/Y Change
Total Assets
37.0B
↓ 5.1%
Total Liabilities
20.8B
↓ 5.92%
Q1 FY23Q/Q Change
Total Assets
37.4B
↓ 2.22%
Total Liabilities
21.4B
↓ 1.35%
Q2 FY23Q/Q Change
Total Assets
37.9B
↑ 0.0%
Total Liabilities
21.7B
↑ 0.0%
Q3 FY23Q/Q Change
Total Assets
38.0B
↑ 1.93%
Total Liabilities
21.6B
↑ 0.85%
Q4 FY23Q/Q Change
Total Assets
37.0B
↓ 4.78%
Total Liabilities
20.8B
↓ 5.43%
Q1 FY24Q/Q Change
Total Assets
37.3B
↑ 1.2%
Total Liabilities
20.9B
↑ 0.53%
Q2 FY24Q/Q Change
Total Assets
36.5B
↓ 1.28%
Total Liabilities
20.1B
↓ 2.58%
FY18Y/Y Change
Operating Cash Flow
2.3B
↓ 5.93%
Investing Cash Flow
-278.7M
↓ 75.29%
Financing Cash Flow
-775.5M
↓ 14.64%
FY19Y/Y Change
Operating Cash Flow
2.9B
↑ 24.49%
Investing Cash Flow
-3.7B
↑ 1241.01%
Financing Cash Flow
-518.5M
↓ 31.55%
FY20Y/Y Change
Operating Cash Flow
5.1B
↑ 64.9%
Investing Cash Flow
-1.6B
↓ 59.37%
Financing Cash Flow
-3.2B
↑ 470.9%
FY21Y/Y Change
Operating Cash Flow
2.8B
↓ 41.2%
Investing Cash Flow
-1.4B
↓ 10.39%
Financing Cash Flow
-1.2B
↓ 61.55%
FY22Y/Y Change
Operating Cash Flow
2.3B
↓ 12.94%
Investing Cash Flow
-777.5M
↓ 38.58%
Financing Cash Flow
-1.7B
↑ 57.89%
Q1 FY23Q/Q Change
Operating Cash Flow
152.9M
↓ 76.19%
Investing Cash Flow
-174.8M
↓ 77.78%
Financing Cash Flow
2.2M
↓ 101.68%
Q2 FY23Q/Q Change
Operating Cash Flow
1.1B
↑ 605.11%
Investing Cash Flow
-321.8M
↑ 81.67%
Financing Cash Flow
-762.1M
↓ 34983.76%
Q3 FY23Q/Q Change
Operating Cash Flow
811.1M
↓ 24.56%
Investing Cash Flow
-478.0M
↑ 50.94%
Financing Cash Flow
-440.2M
↓ 41.31%

Technicals Summary

Sell

Neutral

Buy

Fresenius Medical Care Ag is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Fresenius Medical Care Ag
Fresenius Medical Care Ag
-6.53%
-8.77%
14.55%
-42.05%
-46.64%
Hca Holdings, Inc.
Hca Holdings, Inc.
-11.55%
15.66%
56.72%
43.77%
162.22%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
-3.51%
31.27%
189.34%
124.2%
475.7%
Universal Health Services Inc.
Universal Health Services Inc.
-8.37%
20.82%
62.76%
66.97%
47.11%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-11.01%
-0.46%
81.97%
36.07%
130.3%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Fresenius Medical Care Ag
Fresenius Medical Care Ag
19.94
19.94
0.4
2.51
0.05
0.03
0.03
47.48
Hca Holdings, Inc.
Hca Holdings, Inc.
16.05
16.05
1.16
22.23
0.12
0.12
0.01
-8.39
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
4.94
4.94
0.81
10.57
0.6
0.07
NA
40.32
Universal Health Services Inc.
Universal Health Services Inc.
13.66
13.66
1.87
15.93
0.16
0.07
0.0
99.28
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
15.07
15.07
1.05
9.72
0.45
0.07
NA
4.68
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$11.5B
-46.64%
19.94
2.73%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$90.5B
162.22%
16.05
8.52%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$14.8B
475.7%
4.94
14.91%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$13.7B
47.11%
13.66
6.66%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$11.6B
130.3%
15.07
6.53%

Insights on Fresenius Medical Care Ag

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 4.72B → 4.76B (in $), with an average increase of 0.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 70.95M → 187.0M (in $), with an average increase of 62.1% per quarter

  • Vs THC

    In the last 1 year, Tenet Healthcare Corp.  has given 189.3% return, outperforming this stock by 174.7%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 124.2% return, outperforming this stock by 166.3%

Institutional Holdings

  • Pzena Investment Management, LLC

    2.76%
  • Fiduciary Management, Inc. of Milwaukee

    0.88%
  • Dodge & Cox

    0.72%
  • Morgan Stanley - Brokerage Accounts

    0.33%
  • Goldman Sachs Group Inc

    0.13%
  • BlackRock Inc

    0.08%

Corporate Announcements

  • Fresenius Medical Care Ag Dividends September,2024

    In the quarter ending September,2024. Fresenius Medical Care Ag has declared dividend of $0.63

    Read More

Company Information

Fresenius Medical Care AG & Co. KGaA is an American German healthcare company which provides kidney dialysis services.

Organization
Fresenius Medical Care Ag
Employees
113639
CEO
Ms. Helen Giza
Industry
Health Services

FAQs